Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study

1 September 2019 (11:45 - 11:54)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Professor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

8 More presentations in this session

Presentation thumbnail

Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial

Doctor D. Fouassier (Paris, FR)

Abstract Slides Video

Presentation thumbnail

Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Doctor J. Cheng (Taipei, TW)

Abstract Slides Video

Presentation thumbnail

Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Doctor H. Kihara (Asahikawa, JP)

Abstract Slides Video

Presentation thumbnail

Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Associate Professor A. Kalogeropoulos (Stony Brook, US)

Presentation thumbnail

Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Mr M. Godet (Rouen, FR)

Abstract Slides Video

Access the full session

Session thumbnail

New treatment studies in heart failure

The Event

ESC Congress 2019

1 September 2019 11:45 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources